Namrata Chand
Investor Relations Contact chez Ryca International, Inc.
Profil
Ms. Namrata Chand is a Vice President-Operations & Head-Communications at QSAM Biosciences, Inc. and a Head-Investor Relations & Business Development at Ryca International, Inc.
Postes actifs de Namrata Chand
| Sociétés | Poste | Début |
|---|---|---|
| Ryca International, Inc. | Investor Relations Contact | - |
Anciens postes connus de Namrata Chand
| Sociétés | Poste | Fin |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Directeur des opérations | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
| Ryca International, Inc. |
